Abstract:Objective: To investigate the effect of thrombus aspiration with intra-infarct-related artery(IRA) tirofiban and intravenous tirofiban injection on cardiac function and no-reflow in patients of acute ST-elevation myocardial infarction(STEMI) with emergent PCI treatment. Methods: A total of 90 STEMI patients with emergent PCI treated in our hospital were enrolled and randomly divided into 2 groups. Experimental group, in which the patients received thrombus aspiration with IRA tirofiban injection during PCI, n=44, and Control group, the patients received intravenous tirofiban injection during PCI, n=46. The post procedural plasma levels of NT-proBNP and left ventricular end-systolic diameter(LVESD), LVEDD, left ventricular ejection fraction(LVEF) and major adverse cardiovascular events(MACE) were examined and compared between two groups. Results: Compared with Control group, more patients in Experimental group achieved TIMI 3 flow and had lower level of plasma NT-proBNP, both P0.05. At 30 days after the operation, the Experimental group also showed higher LVEF, lower LVESD, LVEDD and MACE, all P0.05. Conclusion: Emergent PCI with IRA tirofiban injection may reduce the incidence of no-reflow, during PCI, therefore improve the cardiac function and early effect of treatment in STEMI patients.

Effect of Thrombus Aspiration With Intra-infarct-related Artery Tirofiban Injection on Cardiac Function and No-reflow in Patients With Acute ST-elevation Myocardial Infarction